These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 11213439)

  • 1. [Production and characterization of an atenolol-reticulated povodone tablet].
    Dobrecky J; Bregni C; Lamas MC; Cancelo G; Estévez SM
    Boll Chim Farm; 2000; 139(5):209-12. PubMed ID: 11213439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zero-order release of aspirin, theophylline and atenolol in water from novel methylcellulose glutarate matrix tablets.
    Khairuzzaman A; Ahmed SU; Savva M; Patel NK
    Int J Pharm; 2006 Aug; 318(1-2):15-21. PubMed ID: 16621361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation design studies of atenolol tablets.
    Moneghini M; Carcano A; Perissutti B; Rubessa F
    Pharm Dev Technol; 2000; 5(2):297-301. PubMed ID: 10810759
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term stability characterization of a controlled release gastrointestinal therapeutic system coated with a cellulose acetate pseudolatex.
    Vaithiyalingam SR; Sastry SV; Dehon RH; Reddy IK; Khan MA
    Pharmazie; 2001 Jan; 56(1):66-9. PubMed ID: 11210674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of different formulations of atenolol.
    Yasmeen R; Shoaib MH; Khalid H
    Pak J Pharm Sci; 2005 Jan; 18(1):47-51. PubMed ID: 16431383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Peroxide Impurities in Povidone on the Stability of Selected β-Blockers with the Help of HPLC.
    Prachi S; Komal C; Priti MJ
    AAPS PharmSciTech; 2017 Oct; 18(7):2410-2417. PubMed ID: 28155135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisolvent precipitation technique: A very promising approach to crystallize curcumin in presence of polyvinyl pyrrolidon for solubility and dissolution enhancement.
    Sadeghi F; Ashofteh M; Homayouni A; Abbaspour M; Nokhodchi A; Garekani HA
    Colloids Surf B Biointerfaces; 2016 Nov; 147():258-264. PubMed ID: 27518458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solubility of solid dispersions of pizotifen malate and povidone.
    Margarit MV; Marín MT; Contreras MD
    Drug Dev Ind Pharm; 2001 Jul; 27(6):517-22. PubMed ID: 11548858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solubilization and interaction of sulindac with polyvinylpyrrolidone K30 in the solid state and in aqueous solution.
    Tros de Ilarduya MC; Martín C; Goñi MM; Martínez-Ohárriz MC
    Drug Dev Ind Pharm; 1998 Mar; 24(3):295-300. PubMed ID: 9876588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiating amorphous mixtures of cefuroxime axetil and copovidone by X-ray diffraction and differential scanning calorimetry.
    Nicolaï B; Perrin MA; Céolin R; Rietveld IB
    Ann Pharm Fr; 2014 Mar; 72(2):95-100. PubMed ID: 24630310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and stability evaluation of extemporaneously prepared atenolol capsules from crushed atenolol tablets.
    Zaid AN; Malkieh N; Kharoaf M; Abu Ghoush A; Al-Ramahi R
    Int J Pharm Compd; 2012; 16(4):342-6. PubMed ID: 23050394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of povidone K17 on the storage stability of solid dispersions of nimodipine and polyethylene glycol.
    Smikalla MM; Urbanetz NA
    Eur J Pharm Biopharm; 2007 Apr; 66(1):106-12. PubMed ID: 17055711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preparation and application on compound excipient of sodium stearyl fumarate and plasdone S-630].
    Jiang YR; Zhang ZH; Jia XB
    Yao Xue Xue Bao; 2013 Jan; 48(1):125-30. PubMed ID: 23600153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compatibility of atenolol with excipients: LC-MS/TOF characterization of degradation/interaction products, and mechanisms of their formation.
    Kumar V; Shah RP; Malik S; Singh S
    J Pharm Biomed Anal; 2009 May; 49(4):880-8. PubMed ID: 19217740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solubility-modulated monolithic osmotic pump tablet for atenolol delivery.
    Liu L; Wang X
    Eur J Pharm Biopharm; 2008 Feb; 68(2):298-302. PubMed ID: 17560099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and in vitro characterization of non-effervescent floating drug delivery system of poorly soluble drug, carvedilol phosphate.
    Srikanth Meka V; Wee Liang VA; Dharmalingham SR; Sheshala R; Gorajana A
    Acta Pharm; 2014 Dec; 64(4):485-94. PubMed ID: 25531788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development, validation and stability study of pediatric atenolol syrup.
    Foppa T; Murakami FS; Silva MA
    Pharmazie; 2007 Jul; 62(7):519-21. PubMed ID: 17718193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of etoricoxib-beta-cyclodextrin complexes prepared by the kneading method.
    Patel HM; Suhagia BN; Shah SA; Rathod IS; Parmar VK
    Acta Pharm; 2007 Sep; 57(3):351-9. PubMed ID: 17878114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A minitablet formulation made from electrospun nanofibers.
    Poller B; Strachan C; Broadbent R; Walker GF
    Eur J Pharm Biopharm; 2017 May; 114():213-220. PubMed ID: 28167295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.